Tag: Pfizer

FDA Asks Court for 55 Years to Fully Release Pfizer COVID-19 Vaccine Data

The Food and Drug Administration (FDA) asked a federal judge on Nov. 15 to give it until the year 2076 to fully release the documents in its possession tied to the approval of the Pfizer-BioNTech COVID-19 vaccine. The FDA’s request was made in a filing as part of a Freedom of Information Act (FOIA) lawsuit…


Biden Administration Announces Plan to Ramp up Vaccine Manufacturing

The Biden administration announced plans to spend billions of dollars to ramp up United States vaccine production. Officials said on Nov. 17 that the Department of Health and Human Services (HHS) will reach out to mRNA vaccine manufacturers to identify opportunities to scale up production with the goal of increasing capacity to a billion doses…


Pfizer CFO D’Amelio to Retire After 15 Years at Company

Pfizer Inc. said on Wednesday Chief Financial Officer Frank D’Amelio, 63, would retire after nearly 15 years at the company. The drugmaker has started an external search for the successor of D’Amelio, who also served as executive vice president of global supply. During his tenure, Pfizer slimmed down its business through sales to focus on…


FDA to Decide on Pfizer Booster Shots Without Hearing From Expert Panel That Rejected Earlier Bid

U.S. drug regulators will decide whether to greenlight booster doses of Pfizer’s COVID-19 vaccine for all Americans 16 or older without convening its expert vaccine advisory panel, the Food and Drug Administration (FDA) confirmed to The Epoch Times on Wednesday. FDA’s acting head and other top Biden administration officials said earlier this year that booster…


FDA to Decide on Pfizer Booster Shots Without Hearing From Expert Panel

U.S. drug regulators will decide whether to greenlight booster doses of Pfizer’s COVID-19 vaccine for all Americans 16 or older without convening its expert vaccine advisory panel, the Food and Drug Administration (FDA) confirmed to The Epoch Times on Wednesday. FDA’s acting head and other top Biden administration officials said earlier this year that booster…


FDA to Decide on Pfizer Vaccine Booster Shots Without Hearing From Expert Panel

U.S. drug regulators will decide whether to approve booster doses of Pfizer’s COVID-19 vaccine for all Americans aged 16 or older without convening its expert vaccine advisory panel, the Food and Drug Administration (FDA) confirmed to The Epoch Times on Nov. 17. The FDA’s acting head and other top Biden administration officials said earlier in…


Pfizer, BioNTech, Moderna Making $1,000 Every Second From COVID-19 Vaccines: People’s Vaccine Alliance

Pfizer, BioNTech, and Moderna are making thousands of dollars in combined profits every minute from their COVID-19 vaccines, while less than 1 percent of each company’s doses have gone to the world’s poorest countries, according to a new analysis by the People’s Vaccine Alliance (PVA). PVA, a coalition of organizations campaigning for wider access to COVID-19 vaccines, based its calculations…


Pfizer Asks Food and Drug Administration to Authorize COVID-19 Pill

Pfizer on Tuesday said it submitted a request for emergency clearance for a pill designed to treat COVID-19. The treatment, known as Paxlovid, is meant to keep COVID-19 patients with mild or moderate symptoms out of hospitals. It reduced the risk of hospitalization or death in a clinical trial, according to an interim analysis the…


Pfizer Deal Lets Outside Companies Make Drugmaker’s COVID-19 Pill

Pfizer and a United Nations-backed group announced Monday that the drugmaker would let outside companies make its COVID-19 pill. “Pfizer remains committed to bringing forth scientific breakthroughs to help end this pandemic for all people. We believe oral antiviral treatments can play a vital role in reducing the severity of COVID-19 infections, decreasing the strain…


Israel Announces 5 to 11-Year-Olds Now Eligible for Pfizer Vaccine, Following US Emergency Approval

Israeli authorities said on Sunday that minors aged 5 to 11 will now be eligible for the weaker dosing of the Pfizer COVID-19 vaccine after a majority of experts on its advisory committee voted in favor of the vaccine’s safety profile. The decision, announced by Israel’s Health Ministry, cited Pfizer’s clinical trial data, which the…